A highly reliable hERG inhibition prediction tool that eliminates cardiotoxicity risks early in drug development!
Optimization of pharmacokinetic and toxicity parameters is an important goal throughout the drug discovery project. The "ADMET Group" applies machine learning techniques to curated datasets to create reliable predictive models. By predicting hERG inhibition using trained models, we can assess the cardiotoxicity risk of candidate compounds. 【Features】 ■ Application of machine learning techniques to curated datasets ■ Creation of reliable predictive models ■ Prediction of hERG inhibition using trained models ■ Ability to assess cardiotoxicity risk of candidate compounds *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
【Purpose】 ■ Eliminate cardiotoxicity risks early in drug discovery 【Usage】 ■ As a plugin for Marvin Sketch ■ As a cxcalc command line tool ■ As a feature of Chemical Terms ■ Utilized in custom applications using various APIs such as Java, .NET, and Microservices * For more details, please refer to the PDF document or feel free to contact us.
catalog（1）
Download All Catalogs
News about this product（1）
Company information
Patocoa Inc. is a specialized company in drug discovery support systems. We are also focused on improving and streamlining compliance-related operations concerning regulated substances, and we have provided various solutions primarily to pharmaceutical companies, as well as chemical companies, universities, and government agencies. We contribute to accelerating drug discovery and reducing costs with our cutting-edge cheminformatics systems.